SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Chair tenure extension

Today 12:41

RNS Number : 3454I
SThree plc
15 June 2026
 

15 June 2026

 

SThree - Chair tenure extension

 

SThree plc, the global STEM workforce consultancy, announces that, after consultation with shareholders, the Board is extending James Bilefield's tenure as Chair for a seven-month period, until April 2027. This extension allows James, as Chair of the Nomination Committee, to conclude the search for a permanent Chief Financial Officer, before the Nomination Committee turns its focus to Chair succession.

 

James was appointed to the Board in October 2017, becoming Chair in April 2018. James' nine-year term will therefore conclude in September 2026. The Nomination Committee recommended to the Board a short, time-bound extension for James to remain as Chair until the conclusion of the Company's annual general meeting in April 2027.

 

Imogen Joss, Senior Independent Non-Executive Director, commented:

"I am delighted that James has agreed to this short extension of tenure. He has been a strong independent director throughout his time at SThree and a valued source of support to the Executive Team. We are very grateful for his continued contribution and believe this extension is in the best interests of the Company."

 

Enquiries:

 

SThree plc

Timo Lehne, CEO

Damian Fehrenberg, Interim CFO

Charlie Hildesley, Investor Relations Manager

 

 

 via Alma

Alma Strategic Communications

+44 20 3405 0205

 

Rebecca Sanders-Hewett

Hilary Buchanan

Sam Modlin

Rose Docherty

SThree@almastrategic.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCAKPBNDBKDFAD

Related Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Back to RNS